- Global Pharma News & Resources

Press Releases

Date Title Company
29-Aug-2018 ZEISS expands high-accuracy MICURA CMM line ZEISS
29-Aug-2018 DURECT to Present at the 20th Annual Rodman & Renshaw Global Investment Conference DURECT
29-Aug-2018 ImaginAb and CPDC Announce Clinical Trial Supply Manufacture and Distribution Agreement for ImaginAb's CD8 Immuno PET Tracer ImaginAb
29-Aug-2018 RMS Medical Products to Present at the 7th Annual Liolis Gateway Conference RMS Medical Products
29-Aug-2018 iWi® Expands to Sam's Club to Launch Algae-based Omega-3s Nationwide iWi
29-Aug-2018 Oramed to Present at the H.C. Wainwright Global Investment Conference Oramed
29-Aug-2018 MEI Pharma To Present at Wells Fargo Securities 2018 Healthcare Conference MEI Pharma
29-Aug-2018 Rex L. Mahnensmith, M.D., is recognized by Continental Who's Who Continental Who's Who
29-Aug-2018 Reflexion Health Enters Employer Market Through Strategic Partnership With BevCap Management Reflexion Health
29-Aug-2018 InventHelp Inventor Develops Medical Accessory to Facilitate Finding a Vein (CNC-305) InventHelp
29-Aug-2018 DLH Appraised at Capability Maturity Model Integration Level 3 DLH
29-Aug-2018 VirZOOM, Acer Launch Next Generation VR for Fitness at IFA 2018 Berlin VirZOOM
29-Aug-2018 Hiring of Investment Banker Crucial to Neuralstem Success Jon Einsidler
29-Aug-2018 Eric Allyn, Former Chairman Of Welch Allyn, Joins The Board Of Health Care Originals Health Care Originals
29-Aug-2018 European Commission Approves BLINCYTO® (blinatumomab) For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia Amgen
29-Aug-2018 Viking Therapeutics to Participate in Upcoming Investor Conferences Viking Therapeutics
29-Aug-2018 10x Genomics Acquires Epinomics 10x Genomics
29-Aug-2018 Metro Vein Centers Expands, Opens New Center in the Bronx Metro Vein Centers
29-Aug-2018 New blood pressure monitor designed specifically for obese people revealed, as rates of obesity rise across Europe OMRON Healthcare
29-Aug-2018 Vyxeos® Receives Marketing Authorisation in the European Union for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia Jazz Pharmaceuticals